Quest Diagnostics Cash Flow Statement

DGX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.

Quest Diagnostics generated $1.9B in operating cash flow and $1.4B in free cash flow in FY2025. Free cash flow margin was 12.3% of revenue.

Based on SEC 10-K filings.

Key Data Points

High earnings quality (cash-backed earnings)

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Net Income	$992.0M	$871.0M	$2.0B	$1.4B	$858.0M	$1.4B	$772.0M	$645.0M	$709.0M	$556.0M	$849.0M	$556.0M	$471.0M	$556.0M	$471.0M
Depreciation & Amortization	$570.0M	$493.0M	$408.0M	$361.0M	$329.0M	$361.0M	$270.0M	$249.0M	$304.0M	$314.0M	$283.0M	$314.0M	$281.0M	$287.0M	$281.0M
Operating Cash Flow	$1.9B	$1.3B	$2.2B	$2.0B	$1.2B	$2.0B	$1.2B	$1.1B	$821.0M	$944.0M	$652.0M	$944.0M	$895.0M	$1.2B	$895.0M
Capital Expenditures	$527.0M	$425.0M	$403.0M	$418.0M	$400.0M	$418.0M	$252.0M	$293.0M	$263.0M	$308.0M	$231.0M	$308.0M	$161.0M	$182.0M	$161.0M
Free Cash Flow	$1.4B	$909.0M	$1.8B	$1.6B	$843.0M	$1.6B	$923.0M	$823.0M	$558.0M	$636.0M	$421.0M	$636.0M	$734.0M	$1.0B	$734.0M
Share Buybacks	$450.0M	$151.0M	$2.2B	$325.0M	$353.0M	$325.0M	$465.0M	$590.0M	$224.0M	$132.0M	$1.0B	$132.0M	$935.0M	$200.0M	$935.0M
Dividends Paid	$353.0M	$331.0M	$309.0M	$297.0M	$286.0M	$297.0M	$247.0M	$223.0M	$212.0M	$187.0M	$185.0M	$187.0M	$65.0M	$108.0M	$65.0M
FCF Margin	12.3%	9.2%	17.0%	16.8%	10.9%	16.8%	12.5%	11.4%	7.4%	8.6%	5.9%	8.6%	9.9%	13.6%	9.9%

Other Financial Statements

Income Statement Balance Sheet All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Quest Diagnostics Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Net Income

$992.0M

$871.0M

$2.0B

$1.4B

$858.0M

$1.4B

$772.0M

$645.0M

$709.0M

$556.0M

$849.0M

$556.0M

$471.0M

$556.0M

$471.0M

Depreciation & Amortization

$570.0M

$493.0M

$408.0M

$361.0M

$329.0M

$361.0M

$270.0M

$249.0M

$304.0M

$314.0M

$283.0M

$314.0M

$281.0M

$287.0M

$281.0M

Operating Cash Flow

$1.9B

$1.3B

$2.2B

$2.0B

$1.2B

$2.0B

$1.2B

$1.1B

$821.0M

$944.0M

$652.0M

$944.0M

$895.0M

$1.2B

$895.0M

Capital Expenditures

$527.0M

$425.0M

$403.0M

$418.0M

$400.0M

$418.0M

$252.0M

$293.0M

$263.0M

$308.0M

$231.0M

$308.0M

$161.0M

$182.0M

$161.0M

Free Cash Flow

$1.4B

$909.0M

$1.8B

$1.6B

$843.0M

$1.6B

$923.0M

$823.0M

$558.0M

$636.0M

$421.0M

$636.0M

$734.0M

$1.0B

$734.0M

Share Buybacks

$450.0M

$151.0M

$2.2B

$325.0M

$353.0M

$325.0M

$465.0M

$590.0M

$224.0M

$132.0M

$1.0B

$132.0M

$935.0M

$200.0M

$935.0M

Dividends Paid

$353.0M

$331.0M

$309.0M

$297.0M

$286.0M

$297.0M

$247.0M

$223.0M

$212.0M

$187.0M

$185.0M

$187.0M

$65.0M

$108.0M

$65.0M

FCF Margin

12.3%

9.2%

17.0%

16.8%

10.9%

16.8%

12.5%

11.4%

7.4%

8.6%

5.9%

8.6%

9.9%

13.6%

9.9%